explain currency People searches

Second, Contemporary Amperex Technology Co., Limited's enlargement trick: special dividends for factories in EuropeIii. 11 Linked Board Yiming Food: Shareholders reduced their holdings of 138,200 shares today, and there is a risk of a sharp decline in the short term.Iii. 11 Linked Board Yiming Food: Shareholders reduced their holdings of 138,200 shares today, and there is a risk of a sharp decline in the short term.

China Research Institute: Wang Xiuyun reduced its shareholding by 1%. At present, the company has not directly involved in the application field of humanoid robots.Iii. 11 Linked Board Yiming Food: Shareholders reduced their holdings of 138,200 shares today, and there is a risk of a sharp decline in the short term.Yiming Food issued a suggestive announcement on the risk of stock trading. Since November 26, 2024, the company's stock has been trading daily for 11 consecutive times, with a cumulative turnover rate of 66.9%, which is a risk of a sharp decline in the short term. At the same time, several major shareholders reduced their holdings of shares not exceeding 1% of the total share capital. As of the close of December 10, 2024, the three partnership platforms reduced their holdings by 138,200 shares today.

Ningde's business in Europe has made progress. Through cooperation with local European giants, it has invested 30 billion RMB, with each party holding 50% of the shares. This is a new mode of exploring the sea! It is worth noting that this cooperation with Stellantis is mainly to supply lithium iron batteries and drive a new round of electrification in Europe through Ferrous lithium phosphate parity technology, which is a new opportunity from 0 to 1.Wentai Technology: Shareholders plan to reduce their holdings by no more than 2%;Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.